DI BELLA METHOD > DOCUMENTATION INDEX > MDB - Documents

 
 
MDB - Documents
 
 
Identification of somatostatin receptor subtypes 1, 2A, 3, and 5 in neuroendocrine tumours with subtype specific antibodies. (30/05/2003)
Detail
Human ovarian cancers express somatostatin receptors. (30/05/2003)
Detail
The future of somatostatin analogue therapy. (30/05/2003)
Detail
111In-DTPA-D-Phe1-octreotide binding and somatostatin receptor subtypes in thyroid tumors. (30/05/2003)
Detail
The somatostatin analogue peptide TT-232 induces apoptosis and chromosome breakage in cultured human lymphocytes. (30/05/2003)
Detail
Neuropeptide Y Y2 receptor and somatostatin sst2 receptor coupling to mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells. (30/05/2003)
Detail
Somatostatin receptor in breast cancer and axillary nodes: study with scintigraphy, histopathology and receptor autoradiography. (30/05/2003)
Detail
The role of somatostatin analogues in complete antiandrogen treatment in patients with prostatic carcinoma. (30/05/2003)
Detail
The role of nuclear medicine in the evaluation of pancreatic disease. (30/05/2003)
Detail
The role of somatostatin and octreotide in bowel obstruction: pre-clinical and clinical results. (30/05/2003)
Detail
The significance of somatostatin analogues in the antiproliferative treatment of carcinomas. (30/05/2003)
Detail
The surgical management of pancreatic neuroendocrine tumors. (30/05/2003)
Detail
Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study. (30/05/2003)
Detail
The therapeutic value of somatostatin and its analogues. (30/05/2003)
Detail
Imaging tumors with peptide-based radioligands. (30/05/2003)
Detail
 
 
 
Scorri con le frecce per visualizzare le pagine della ricerca 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 |
 
 

Stampa